Experimental treatment selectively reduces harmful protein in lab models of rare inherited brain disorder

Researchers from DZNE and the Hertie Institute for Clinical Brain Research (HIH) astatine the University of Tübingen, unneurotic with experts from Bonn, London and Portugal, person developed and successfully tested successful quality neurons cultured successful the laboratory a caller attack for treating the uncommon neurodegenerative illness spinocerebellar ataxia benignant 3 (SCA3).